Latin-American Clinical Care Center for Peritoneal Neoplasms

Latin-American Clinical Care Center for Peritoneal Neoplasms, a multidisciplinary approach for an underrated disease




Some decades ago, patients with tumors of the appendix, ovary, colon, stomach and mesothelioma with involvement of the peritoneum were considered to have no therapeutic option with curative intention. Cytoreductive surgery (CCR) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) appeared in the 1980’s in the United States as a procedure with curative intent that has been shown to be safe. Thus, our program was born in 2007 as a pioneering center in Colombia that, to date, has more than 10 years of experience in the comprehensive treatment of patients with this condition. From the beginning, we have been characterized by continuous improvement, search for knowledge and relentless work to give patient the most qualified care. These, through a highly specialized team, advanced surgical techniques and state of the art technology attaining in October 2015 the certification as a Clinical Care Center for the treatment of patients with Peritoneal Neoplasms by the Joint Commission International and the recertification in 2018 for the continuous compliance with quality standards.

We offer a high quality 1st-world service in a 3rd-world country. Our team involves multiple medical specialties including oncologic surgery, colorectal surgery, oncology, urology, gynecology, anesthesia, radiology, pathology among others, as well as health professionals such as nurses, physical and respiratory therapists, social workers and many more, that have focus on quality, on giving their best of their ability to serve the complex and interrelated needs of each our patients.

Our patients involved any patient, from Colombia and other Latin-American countries, with peritoneal carcinomatosis. They are involved since the first moment they enter the outpatient room, being engaged in a culture of self-care and active participation in the process of decision-making.

During the hospital stay, our team carefully follows the process in order to prevent adverse events and real-time information about the patient’s status and medical decisions is constantly being provided to the main team.